These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27029500)

  • 21. Preliminary Experience with Transdermal Oxybutynin Patches for Hyperhidrosis.
    Bergón-Sendín M; Pulido-Pérez A; Sáez-Martín LC; Suárez-Fernández R
    Actas Dermosifiliogr; 2016 Dec; 107(10):845-850. PubMed ID: 27497508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical Oxybutynin 10% Gel for the Treatment of Primary Focal Hyperhidrosis: A Randomized Double-blind Placebo-controlled Split Area Study.
    Artzi O; Loizides C; Zur E; Sprecher E
    Acta Derm Venereol; 2017 Oct; 97(9):1120-1124. PubMed ID: 28654131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxybutynin as a treatment for generalized hyperhidrosis: a randomized, placebo-controlled trial.
    Schollhammer M; Brenaut E; Menard-Andivot N; Pillette-Delarue M; Zagnoli A; Chassain-Le Lay M; Sassolas B; Jouan N; Le Ru Y; Abasq-Thomas C; Greco M; Penven K; Roguedas-Contios AM; Dupré-Goetghebeur D; Gouedard C; Misery L; Le Gal G
    Br J Dermatol; 2015 Nov; 173(5):1163-8. PubMed ID: 26114588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results of the treatment of primary hyperhidrosis with oxybutynin: follow-up of 1,658 cases.
    Wolosker N; Kauffman P; de Campos JRM; Faustino CB; da Silva MFA; Teivelis MP; Puech-Leão P
    Int J Dermatol; 2020 Jun; 59(6):709-715. PubMed ID: 32301117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects With Primary Focal Hyperhidrosis.
    Pariser DM; Krishnaraja J; Tremblay TM; Rubison RM; Love TW; McGraw BF
    J Drugs Dermatol; 2017 Feb; 16(2):127-132. PubMed ID: 28300854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-life experience with oral oxybutynin long-term continuous therapy in severe hyperhidrosis and systematic review of the literature.
    Briatico G; Pampena R; Fulgione E; Babino G; Giorgio CM; D'Ambra I; Caccavale S; Longo C; Argenziano G
    Dermatol Ther; 2021 Mar; 34(2):e14832. PubMed ID: 33527699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of oxybutynin treatment for hyperhidrosis in patients aged over 40 years.
    Wolosker N; Krutman M; Teivelis MP; Paula RP; Kauffman P; Campos JR; Puech-Leão P
    Einstein (Sao Paulo); 2014; 12(1):42-7. PubMed ID: 24728245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methadone-Induced Hyperhidrosis Treated With Oxybutynin.
    Hong J; Lee J; Totouom-Tangho H; Dunn NR; Swift RG
    J Addict Med; 2017; 11(3):237-238. PubMed ID: 28244893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial - oxybutynin for treatment of persistent plantar hyperhidrosis in women after sympathectomy.
    Costa Ada S; Leão LE; Succi JE; Perfeito JA; Filho Castelo A; Rymkiewicz E; Filho Aurelio Marchetti M
    Clinics (Sao Paulo); 2014 Feb; 69(2):101-5. PubMed ID: 24519200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hyperhidrosis with oxybutynin.
    Schollhammer M; Misery L
    Arch Dermatol; 2007 Apr; 143(4):544-5. PubMed ID: 17438194
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxybutynin as an alternative treatment for hyperhidrosis.
    Delort S; Marchi E; Corrêa MA
    An Bras Dermatol; 2017; 92(2):217-220. PubMed ID: 28538882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxybutynin for antidepressant-induced hyperhidrosis.
    Grootens KP
    Am J Psychiatry; 2011 Mar; 168(3):330-1. PubMed ID: 21368313
    [No Abstract]   [Full Text] [Related]  

  • 33. Glycopyrrolate-induced craniofacial compensatory hyperhidrosis successfully treated with oxybutynin: report of a novel adverse effect and subsequent successful treatment.
    Prouty ME; Fischer R; Liu D
    Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Efficacy of Oxybutynin for Palmar and Plantar Hyperhidrosis in Children Younger than 14 Years.
    Wolosker N; Teivelis MP; Krutman M; de Paula RP; Schvartsman C; Kauffman P; de Campos JR; Puech-Leão P
    Pediatr Dermatol; 2015; 32(5):663-7. PubMed ID: 25490865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival study of treatment adherence by patients given oral glycopyrrolate for hyperhidrosis following treatment failure with oral oxybutynin.
    Del Boz J; García-Souto F; Rivas-Ruiz F; Polo-Padillo J
    Dermatol Ther; 2020 Nov; 33(6):e14210. PubMed ID: 32827198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral glycopyrrolate after the failure of oral oxybutynin in the treatment of primary hyperhidrosis.
    Del Boz J; Millán-Cayetano JF; Rivas-Ruiz F; de Troya-Martín M
    Br J Dermatol; 2017 Mar; 176(3):821-823. PubMed ID: 27436700
    [No Abstract]   [Full Text] [Related]  

  • 37. Compensatory hyperhidrosis: results of pharmacologic treatment with oxybutynin.
    Teivelis MP; Wolosker N; Krutman M; Milanez de Campos JR; Kauffman P; Puech-Leão P
    Ann Thorac Surg; 2014 Nov; 98(5):1797-802. PubMed ID: 25173719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxybutynin 3% gel for the treatment of primary focal hyperhidrosis in adolescents and young adults.
    Nguyen NV; Gralla J; Abbott J; Bruckner AL
    Pediatr Dermatol; 2018 Mar; 35(2):208-212. PubMed ID: 29334132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral Oxybutynin for Local and Multifocal Hyperhidrosis: A Multicenter Study.
    Toledo-Pastrana T; Márquez-Enríquez J; Millán-Cayetano JF
    Actas Dermosifiliogr; 2017; 108(6):597-599. PubMed ID: 28388990
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of oxybutynin for treating axillary hyperhidrosis.
    Wolosker N; de Campos JR; Kauffman P; Neves S; Munia MA; BiscegliJatene F; Puech-Leão P
    Ann Vasc Surg; 2011 Nov; 25(8):1057-62. PubMed ID: 22023940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.